ZY
ZYXIQ
ZYNEX INC
No data for this timeframe.
Vol
Inst. Holders1 funds
Inst. Value$1.3K
Inst. Activity1 buys / 7 sells
SEC Reports2
Recent Activity
Mar 26, 2026
SEC
Zynex, Inc. has terminated its SEC registration and suspended reporting obligations following a Chapter 11 bankruptcy re
15-12G — Impact 8/10
Mar 19, 2026
SEC
ZYNEX INC has filed an EFFECT notice, indicating that a previously filed registration statement (File No. 333-232367) ha
EFFECT — Impact 4/10
Inst.
CWM, LLC — NEAR_EXIT
312 shares (—)
Inst.
D. E. Shaw & — ADD
229,524 shares ($332.8K)
Analyst Ratings
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 1, 2025 | HC Wainwright & Co. | DOWNGRADE | Buy → Neutral |
| Jul 15, 2025 | RBC Capital | MAINTAIN | Sector Perform → Sector Perform |
| Jun 30, 2025 | HC Wainwright & Co. | REITERATE | Buy → Buy |
Latest Reports
BEARISH
15-12G
8/10
Zynex, Inc. has terminated its SEC registration and suspended reporting obligations following a Chapter 11 bankruptcy re
Mar 26, 2026
NEUTRAL
EFFECT
4/10
ZYNEX INC has filed an EFFECT notice, indicating that a previously filed registration statement (File No. 333-232367) ha
Mar 19, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BARCLAYS PLC | $1.3K | TRIM |
1 institutional holders with $1.3K total value (10,652 shares) as of 2025-Q4. Top holders: BARCLAYS.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BARCLAYS PLC | 10,652 | $1.3K | 100.0% | TRIM -60.9% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| CWM, LLC | NEAR_EXIT | 2,373 | 312 | -86.9% | — | 2025-Q3 |
| D. E. Shaw & Co., Inc. | ADD | 152,372 | 229,524 | +50.6% | $332.8K | 2025-Q3 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | TRIM | 247,698 | 171,456 | -30.8% | $248.6K | 2025-Q3 |
| MORGAN STANLEY | TRIM | 29,935 | 17,552 | -41.4% | $25.5K | 2025-Q3 |
| Jain Global LLC | TRIM | 31,295 | 16,744 | -46.5% | $24.3K | 2025-Q3 |
| UBS Group AG | TRIM | 18,510 | 10,890 | -41.2% | $15.8K | 2025-Q3 |
| GROUP ONE TRADING LLC | NEAR_EXIT | 19,112 | 4,163 | -78.2% | $6.0K | 2025-Q3 |
| FMR LLC | NEAR_EXIT | 72,326 | 137 | -99.8% | $198.00 | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | ADD | 120,183 | 220,070 | +83.1% | $567.8K | 2025-Q2 |
| STATE STREET CORP | NEAR_EXIT | 360,526 | 78,068 | -78.3% | $201.4K | 2025-Q2 |
| ROYAL BANK OF CANADA | DOUBLED | 1,677 | 21,576 | +1186.6% | $56.0K | 2025-Q2 |
| UBS Group AG | TRIM | 34,529 | 18,510 | -46.4% | $47.8K | 2025-Q2 |
| ROYCE & ASSOCIATES LP | ADD | 10,863 | 17,689 | +62.8% | $45.6K | 2025-Q2 |
| FEDERATED HERMES, INC. | DOUBLED | 2,177 | 8,299 | +281.2% | $21.4K | 2025-Q2 |
| BARCLAYS PLC | TRIM | 27,259 | 10,652 | -60.9% | $28.00 | 2025-Q2 |
| CWM, LLC | DOUBLED | 207 | 2,373 | +1046.4% | $6.00 | 2025-Q2 |
| CWM, LLC | ADD | 129 | 207 | +60.5% | — | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | ADD | 82,094 | 120,183 | +46.4% | $264.4K | 2025-Q1 |
| UBS Group AG | TRIM | 46,773 | 34,529 | -26.2% | $76.0K | 2025-Q1 |
| CITIGROUP INC | TRIM | 19,888 | 10,867 | -45.4% | $23.9K | 2025-Q1 |
| ROYCE & ASSOCIATES LP | NEAR_EXIT | 221,027 | 10,863 | -95.1% | $23.9K | 2025-Q1 |
| ROYAL BANK OF CANADA | DOUBLED | 732 | 1,677 | +129.1% | $4.0K | 2025-Q1 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | TRIM | 746,380 | 550,580 | -26.2% | $4.4M | 2024-Q4 |
| UBS Group AG | DOUBLED | 5,380 | 46,773 | +769.4% | $374.7K | 2024-Q4 |
| STATE OF WISCONSIN INVESTMENT BOARD | TRIM | 42,899 | 30,600 | -28.7% | $245.1K | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 6.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
2 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Aug 1, 2025 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
| Jul 15, 2025 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| Jun 30, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.